Musculoskeletal Chronic Graft versus Host Disease-A Rare Complication to Allogeneic Hematopoietic Stem Cell Transplant: A Case-Based Report and Review of the Literature

被引:3
|
作者
Kvinge, Alexander Datland [1 ]
Kvammen, Tobias [1 ]
Miletic, Hrvoje [2 ,3 ]
Bindoff, Laurence Albert [4 ,5 ]
Reikvam, Hakon [1 ,6 ]
机构
[1] Univ Bergen, Inst Clin Sci, Fac Med, N-5021 Bergen, Norway
[2] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway
[3] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway
[4] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway
[5] Univ Bergen, Inst Med Sci, Fac Med, N-5021 Bergen, Norway
[6] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway
关键词
allogenic hematopoietic stem cell transplantation; graft-versus-host disease; musculoskeletal pathology; fasciitis; myositis; creatine kinase; immunosuppressive treatment; CONSENSUS DEVELOPMENT PROJECT; CLINICAL-TRIALS; CHRONIC GVHD; POLYMYOSITIS; MANIFESTATION; MYOSITIS; DIAGNOSIS; PATHOLOGY; CRITERIA;
D O I
10.3390/curroncol29110663
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Musculoskeletal graft versus host disease (GVHD) is a rare manifestation of chronic GVHD (cGVHD) following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Left untreated, the disease can cause extensive damage to muscle tissue and joints. We describe a 62-year-old male with musculoskeletal GVHD and generalized muscle pain and stiffness. In addition, we performed a systemic literature review based on published cases of musculoskeletal GVHD between 1983 and 2019. We identified 85 cases, 62% male and 38% female with an age of 4-69 years and median age of 39 years at diagnosis. The majority of patients (72%) also had manifestations of cGVHD in at least one other organ system, most frequently the skin (52%), followed by oropharyngeal mucosa (37%), and pulmonary and gastrointestinal tract (GI tract) (21%). We conclude that, while musculoskeletal cGVHD is a rare complication of allo-HSCT, it remains a serious and debilitating risk that must be considered in patients with muscle pain, muscle weakness, joint stiffness, and tissue inflammation. Early intervention is critical for the patient's prognosis.
引用
收藏
页码:8415 / 8430
页数:16
相关论文
共 50 条
  • [31] Nephrotic syndrome as a complication of chronic graft-versus-host disease after allogeneic haemopoietic stem cell transplantation
    Wong, E.
    Lasica, M.
    He, S. Z.
    Bajel, A.
    Roberts, A. W.
    Mason, K. D.
    Ritchie, D. S.
    Szer, J.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (06) : 737 - 741
  • [32] Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation
    Lertkovit, Oranooj
    Anurathapan, Usanarat
    Hongeng, Suradej
    Thokanit, Nintita Sripaiboonkit
    Pakakasama, Samart
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (04) : 556 - 565
  • [33] Refractory inflammatory myopathy in hematopoietic stem cell transplant patients with chronic graft-versus-host disease: report of two cases
    Golec, Sophia
    Rabinovich, Emma
    Cohen, Mark
    Baer, Linda
    Chamoun, Kamal
    Lima, Marcos de
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2019, 41 (03) : 268 - 271
  • [34] Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning
    Poloni, Antonella
    Sartini, Davide
    Emanuelli, Monica
    Trappolini, Silvia
    Mancini, Stefania
    Pozzi, Valentina
    Costantini, Benedetta
    Serrani, Federica
    Berardinelli, Eleonora
    Renzi, Elisabetta
    Olivieri, Attilio
    Leoni, Pietro
    CYTOKINE, 2011, 53 (03) : 376 - 383
  • [35] Alloimmune Myositis as Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature Discussion
    Woelfinger, Pascal
    Hauptrock, Beate
    Kriege, Oliver
    Wagner, Wilfried
    Heider, Julia
    Schwarting, Andreas
    Birklein, Frank
    Theobald, Matthias
    Wagner-Drouet, Eva Maria
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (04) : 1365 - 1368
  • [36] Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study
    Jin, Hua
    Fan, Zhiping
    Huang, Fen
    Chai, Yanyan
    Xuan, Li
    Lin, Ren
    Xu, Na
    Ye, Jieyu
    Sun, Jing
    Liu, Qifa
    INFECTION, 2019, 47 (02) : 275 - 284
  • [37] Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease
    Krishna, Gopal
    Martinho, Monika
    Chandrasekar, Pranatharthi
    Ullmann, Andrew J.
    Patino, Hernando
    PHARMACOTHERAPY, 2007, 27 (12): : 1627 - 1636
  • [38] Candida krusei pneumonia in graft-versus-host disease after allogeneic hematopoietic stem cell transplant for paroxysmal nocturnal hemoglobinuria: a case report
    Zoowa, Ronit
    Shah, Ravi
    Pradhan, Dipana
    Karmacharya, Sammridhi
    Bhandari, Dipen
    ANNALS OF MEDICINE AND SURGERY, 2023, 85 (12): : 6168 - 6172
  • [39] Delayed diagnosis of ocular graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Liao, Yinglin
    Zhao, Wenxin
    Yang, Jing
    Li, Jing
    Chen, Juejing
    Chen, Ziyan
    Jin, Ling
    Li, Longyue
    Huang, Fen
    Liang, Lingyi
    OCULAR SURFACE, 2024, 34 : 1 - 8
  • [40] Risk of graft-versus-host disease with rituximab-containing conditioning regimens in allogeneic hematopoietic stem cell transplant
    Marini, Bernard L.
    Markstrom, Denise
    Frame, David
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (04) : 255 - 263